Biotage AB (publ) (BIOT.ST)
SEK 141.1
(0.21%)
SEK 141.1
(0.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.86 Billion SEK | 18.9% |
| 2022 | 1.56 Billion SEK | 27.11% |
| 2021 | 1.23 Billion SEK | 12.79% |
| 2020 | 1.09 Billion SEK | -0.83% |
| 2019 | 1.1 Billion SEK | 20.91% |
| 2018 | 910.89 Million SEK | 21.75% |
| 2017 | 748.14 Million SEK | 12.01% |
| 2016 | 667.91 Million SEK | 9.4% |
| 2015 | 610.53 Million SEK | 24.5% |
| 2014 | 490.38 Million SEK | 10.29% |
| 2013 | 444.64 Million SEK | -3.95% |
| 2012 | 462.94 Million SEK | 8.06% |
| 2011 | 428.4 Million SEK | -0.12% |
| 2010 | 428.92 Million SEK | 8.83% |
| 2009 | 394.12 Million SEK | 2.29% |
| 2008 | 385.29 Million SEK | -22.38% |
| 2007 | 496.4 Million SEK | -4.45% |
| 2006 | 519.49 Million SEK | 20.7% |
| 2005 | 430.39 Million SEK | 17.39% |
| 2004 | 366.64 Million SEK | 111.14% |
| 2003 | 173.65 Million SEK | 77.96% |
| 2002 | 97.58 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 490 Million SEK | -2.78% |
| 2024 Q2 | 504 Million SEK | 5.0% |
| 2024 Q1 | 480 Million SEK | -25.35% |
| 2023 Q1 | 361 Million SEK | -5.99% |
| 2023 FY | 1.86 Billion SEK | 18.9% |
| 2023 Q3 | 449 Million SEK | 9.78% |
| 2023 Q2 | 409 Million SEK | 13.3% |
| 2023 Q4 | 643 Million SEK | 43.21% |
| 2022 Q3 | 401 Million SEK | 1.26% |
| 2022 FY | 1.56 Billion SEK | 27.11% |
| 2022 Q1 | 386 Million SEK | 12.87% |
| 2022 Q2 | 396 Million SEK | 2.59% |
| 2022 Q4 | 384 Million SEK | -4.24% |
| 2021 FY | 1.23 Billion SEK | 12.79% |
| 2021 Q1 | 281.35 Million SEK | -5.63% |
| 2021 Q2 | 303.45 Million SEK | 7.86% |
| 2021 Q4 | 342 Million SEK | 12.13% |
| 2021 Q3 | 305 Million SEK | 0.51% |
| 2020 Q1 | 277.33 Million SEK | -3.9% |
| 2020 FY | 1.09 Billion SEK | -0.83% |
| 2020 Q4 | 298.12 Million SEK | 13.53% |
| 2020 Q3 | 262.58 Million SEK | 3.29% |
| 2020 Q2 | 254.22 Million SEK | -8.33% |
| 2019 FY | 1.1 Billion SEK | 20.91% |
| 2019 Q3 | 282.66 Million SEK | 0.2% |
| 2019 Q2 | 282.1 Million SEK | 13.74% |
| 2019 Q1 | 248.01 Million SEK | 5.73% |
| 2019 Q4 | 288.59 Million SEK | 2.1% |
| 2018 Q1 | 208.04 Million SEK | 10.14% |
| 2018 FY | 910.89 Million SEK | 21.75% |
| 2018 Q2 | 236.07 Million SEK | 13.47% |
| 2018 Q3 | 232.2 Million SEK | -1.64% |
| 2018 Q4 | 234.57 Million SEK | 1.02% |
| 2017 Q3 | 177.71 Million SEK | -9.47% |
| 2017 Q1 | 185.22 Million SEK | 3.39% |
| 2017 Q2 | 196.31 Million SEK | 5.99% |
| 2017 FY | 748.14 Million SEK | 12.01% |
| 2017 Q4 | 188.88 Million SEK | 6.29% |
| 2016 Q4 | 179.14 Million SEK | 7.25% |
| 2016 FY | 667.91 Million SEK | 9.4% |
| 2016 Q2 | 162.85 Million SEK | 2.51% |
| 2016 Q1 | 158.87 Million SEK | -5.74% |
| 2016 Q3 | 167.03 Million SEK | 2.56% |
| 2015 FY | 610.53 Million SEK | 24.5% |
| 2015 Q4 | 168.54 Million SEK | 12.59% |
| 2015 Q3 | 149.69 Million SEK | 1.07% |
| 2015 Q2 | 148.11 Million SEK | 2.73% |
| 2015 Q1 | 144.17 Million SEK | 4.66% |
| 2014 FY | 490.38 Million SEK | 10.29% |
| 2014 Q2 | 120.38 Million SEK | 5.86% |
| 2014 Q3 | 118.52 Million SEK | -1.54% |
| 2014 Q1 | 113.71 Million SEK | -6.52% |
| 2014 Q4 | 137.75 Million SEK | 16.23% |
| 2013 Q3 | 103.41 Million SEK | -11.11% |
| 2013 FY | 444.64 Million SEK | -3.95% |
| 2013 Q1 | 103.23 Million SEK | -9.4% |
| 2013 Q2 | 116.34 Million SEK | 12.7% |
| 2013 Q4 | 121.64 Million SEK | 17.63% |
| 2012 Q4 | 113.94 Million SEK | 6.35% |
| 2012 Q3 | 107.13 Million SEK | -12.39% |
| 2012 Q1 | 119.57 Million SEK | 3.06% |
| 2012 Q2 | 122.28 Million SEK | 2.26% |
| 2012 FY | 462.94 Million SEK | 8.06% |
| 2011 FY | 428.4 Million SEK | -0.12% |
| 2011 Q2 | 98.62 Million SEK | -7.99% |
| 2011 Q3 | 106.55 Million SEK | 8.03% |
| 2011 Q4 | 116.03 Million SEK | 8.9% |
| 2011 Q1 | 107.19 Million SEK | -7.66% |
| 2010 Q3 | 109.46 Million SEK | 5.76% |
| 2010 Q2 | 103.5 Million SEK | 3.64% |
| 2010 Q1 | 99.86 Million SEK | 0.35% |
| 2010 FY | 428.92 Million SEK | 8.83% |
| 2010 Q4 | 116.09 Million SEK | 6.05% |
| 2009 Q2 | 104.41 Million SEK | 4.84% |
| 2009 Q4 | 99.51 Million SEK | 9.84% |
| 2009 Q1 | 99.59 Million SEK | 0.0% |
| 2009 FY | 394.12 Million SEK | 2.29% |
| 2009 Q3 | 90.6 Million SEK | -13.23% |
| 2008 FY | 385.29 Million SEK | -22.38% |
| 2007 FY | 496.4 Million SEK | -4.45% |
| 2006 FY | 519.49 Million SEK | 20.7% |
| 2005 FY | 430.39 Million SEK | 17.39% |
| 2004 FY | 366.64 Million SEK | 111.14% |
| 2003 FY | 173.65 Million SEK | 77.96% |
| 2002 FY | 97.58 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AddLife AB (publ) | 9.68 Billion SEK | 80.774% |
| Bonesupport Holding AB (publ) | 591.07 Million SEK | -215.018% |
| Doxa AB (publ) | 9.9 Million SEK | -18708.081% |
| Elekta AB (publ) | 18.11 Billion SEK | 89.723% |
| iZafe Group AB (publ) | 1.82 Million SEK | -102095.39% |
| Ortivus AB (publ) | 84.08 Million SEK | -2114.531% |
| Ortivus AB (publ) | 84.08 Million SEK | -2114.531% |
| Q-linea AB (publ) | 4.44 Million SEK | -41836.937% |
| S2Medical AB (publ) | 6.97 Million SEK | -26609.333% |
| Synsam AB (publ) | 5.9 Billion SEK | 68.467% |